All Stories

  1. Applications and Challenges of Digital Health in Rheumatology
  2. Inequality in Burden of Tracheal, Bronchial, and Lung Cancer Attributable to Residential Radon Exposure: Global Analysis and Country‐Level Patterns in High Granite/Marble Consuming Countries
  3. Associations of chronic disease status and the risk of new-onset hip or femoral fractures in older population
  4. Epidemiological and experimental evidence of environmental factor-related autoimmune thyroid disease: A systematic review
  5. Global, regional, and national burden of environmental heat and cold exposure in adults aged 55 years and older from 1990 to 2021: a trend analysis
  6. Burden and Predictions of Untreated Caries in China, 1990–2039: A Systematic Analysis for the Global Burden of Disease Study 2019
  7. Evolutionary patterns and future perspectives of joint replacement in arthritis patients: a comprehensive analysis of findings over the past decades
  8. The impact of population ageing on musculoskeletal disorders in 204 countries and territories, 1990-2021: global burden and healthcare costs
  9. Temporal Trend and Health Inequality in the Burden of Autoimmune Diseases Among Older Adolescents and Young Adults Aged 15-29 Years
  10. Investigation of Genetic Causality Between Epstein–Barr Virus Infection and Risk of Autoimmune Diseases
  11. Leveraging Bibliometric Methods to Uncover the Research Landscape Within the Field of Rheumatology
  12. Rheumatic Diseases and Sinusitis: Epidemiological Features, Immune Mechanisms, and Treatment Challenges
  13. Global landscape of neonatal disorders attributed to environmental and maternal risks over three decades
  14. Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
  15. Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period
  16. Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factors
  17. Global, regional, and national perspectives on aortic aneurysm burden from 1992 to 2021: temporal patterns and age-period-cohort analyses
  18. Genetic Insights Into the Relationship Between Menstrual Factors and Site‐/Age‐Specific Bone Mineral Density
  19. Association Between Mixed Exposure to Dioxins and Dioxin-Like Polychlorinated Biphenyls and Obesity Among US Adults
  20. Global Burden of Diseases Dataset, Methodology and Its Use in Rheumatic and Musculoskeletal Diseases
  21. Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study
  22. Genetic causality between modifiable risk factors and the risk of rheumatoid arthritis: Evidence from Mendelian randomization
  23. Global burden of musculoskeletal disorders in children and adolescents from 1990 to 2021: a joint point regression and decomposition analysis
  24. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: A population-based study
  25. Infodemiology as a Powerful Tool in Public Health: Bridging the Digital Divide for Better Well-being
  26. Differences in the expression of long noncoding RNAs in peripheral blood mononuclear cells indicate potential biomarkers for rheumatoid arthritis
  27. Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia
  28. Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases
  29. Association of gene polymorphisms and the decreased expression of long non-coding RNA LOC553103 with rheumatoid arthritis
  30. Transmission Dynamics and Spatiotemporal Evolution of H1N1pdm09 in Anhui Province, China, 2009--2023
  31. Genetic Links Between Metabolic Syndrome and Osteoarthritis: Insights From Cross-Trait Analysis
  32. Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic
  33. Changes in frailty and depressive symptoms among middle-aged and older Chinese people: a nationwide cohort study
  34. Associations between air pollutants and acute exacerbation of drug-resistant tuberculosis: evidence from a prospective cohort study
  35. Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants
  36. Serum albumin mediates the associations between heavy metals and two novel systemic inflammation indexes among U.S. adults
  37. Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019
  38. Causal Relationships between Air Pollutant Exposure and Bone Mineral Density and the Risk of Bone Fractures: Evidence from a Two-Stage Mendelian Randomization Analysis
  39. Global, regional and national burden of CKD in children and adolescents from 1990 to 2019
  40. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019
  41. Salt reduction behavior of adults in Anhui province in 2019: a cross-sectional survey of 3,378 participants
  42. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040
  43. Impact of short-term exposure to ambient air pollution on osteoarthritis: a multi-city time-series analysis in Central-Eastern China
  44. Changes in frailty and depressive symptoms among middle-aged and elderly Chinese: a nationwide cohort study
  45. Homocysteine as a trigger and potential therapeutic target for autoimmune diseases
  46. The effect of air pollution exposure on the risk of outpatient visits for periodontitis: a time-series study
  47. Climate change and daily outpatient visits for dermatomyositis in Hefei, China: a time-series study
  48. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
  49. Emerging roles of air pollution and meteorological factors in autoimmune eye diseases
  50. Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019
  51. Global Chronic obstructive pulmonary disease burden attributable to air pollution from 1990 to 2019
  52. Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization
  53. Effectiveness of the recurrent laryngeal nerve monitoring during endoscopic thyroid surgery: systematic review and meta-analysis
  54. No genetically predicted association between sarcopenia and COVID-19
  55. Association between short-term exposure to ambient air pollution and outpatient visits for pulpitis in Hefei, China: a time series study
  56. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019
  57. Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period
  58. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases
  59. The effect of air pollution exposure on risk of outpatient visits for Sjogren's syndrome: A time-series study
  60. Associations between particulate matter air pollutants and hospitalization risk for systemic lupus erythematosus: a time-series study from Xi’an, China
  61. Arthritis and incident pulmonary diseases in middle-aged and elderly Chinese: a longitudinal population-based study
  62. Shared genetic architecture between type 2 diabetes and COVID-19 severity
  63. Novel insight into the aetiology of rheumatoid arthritis gained by a cross-tissue transcriptome-wide association study
  64. Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective
  65. Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis
  66. Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic
  67. Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
  68. Association Between Genetic Polymorphisms of lncRNA NEAT1 and Pulmonary Tuberculosis Risk, Clinical Manifestations in a Chinese Population
  69. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus
  70. Social Support and Depression Among Pulmonary Tuberculosis Patients in Anhui, China
  71. New‐onset autoimmune phenomena post‐COVID‐19 vaccination
  72. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F‐FDG PET/CT for Patients with Colorectal Cancer
  73. Association between non-optimal temperature and hospitalizations for gout in Anqing, China: a time-series analysis
  74. Emerging role of air pollution in chronic kidney disease
  75. Association between ambient air pollution and tuberculosis risk: A systematic review and meta-analysis
  76. TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population
  77. Lower-than-standard particulate matter air pollution reduced life expectancy in Hong Kong: A time-series analysis of 8.5 million years of life lost
  78. Non-causal Effect of Circulating Vitamin D Levels on the Risk of Rheumatoid Arthritis: A Two-sample Mendelian Randomization Study
  79. Emerging role of air pollution and meteorological parameters in COVID‐19
  80. Single Immunoglobulin IL‐1‐Related Receptor (SIGIRR) Gene rs7396562 Polymorphism and Expression Level in Rheumatoid Arthritis
  81. Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
  82. Association of Leptin Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Population
  83. Associations of extreme temperatures with hospitalizations and post-discharge deaths for stroke: What is the role of pre-existing hyperlipidemia?
  84. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study
  85. Identification of new susceptibility loci associated with rheumatoid arthritis
  86. Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study
  87. Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population
  88. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy
  89. Association of Melatonin Pathway Gene’s Single-Nucleotide Polymorphisms with Systemic Lupus Erythematosus in a Chinese Population
  90. Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study
  91. Therapeutic potential of aryl hydrocarbon receptor in autoimmunity
  92. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis
  93. Seasonality and global public interest in psoriasis: an infodemiology study
  94. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus
  95. Plasma galectin‐3 levels do not differ in systemic lupus erythematosus patients
  96. Correction: Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  97. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus
  98. Semaphorin-3A, semaphorin-7A gene single nucleotide polymorphisms, and systemic lupus erythematosus susceptibility
  99. Association between Interleukin 35 Gene Single Nucleotide Polymorphisms and Systemic Lupus Erythematosus in a Chinese Han Population
  100. Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  101. Differentially expressed circular RNAs in systemic lupus erythematosus and their clinical significance
  102. Emerging role of lncRNAs in systemic lupus erythematosus
  103. Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  104. Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  105. The expression levels of long noncoding RNAs lnc0640 and lnc5150 and its gene single-nucleotide polymorphisms in rheumatoid arthritis patients
  106. RNAi Silencing of HIF-1α Ameliorates Lupus Development in MRL/lpr Mice
  107. Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  108. Association of single nucleotide polymorphisms in resistin gene with rheumatoid arthritis in a Chinese population
  109. Postpartum depressive mood (PDM) among Chinese women: a meta-analysis
  110. NLRP3: A promising therapeutic target for autoimmune diseases
  111. Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients
  112. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis
  113. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus
  114. Meta-analysis of GWAS on both Chinese and European populations identifies GPR173 as a novel X chromosome susceptibility gene for SLE
  115. Emerging role of semaphorin-3A in autoimmune diseases
  116. Identification ofST3AGL4,MFHAS1, CSNK2A2andCD226as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning
  117. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients
  118. Association ofinterleukin-10gene single nucleotide polymorphisms with rheumatoid arthritis in a Chinese population
  119. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population
  120. Potential link between m 6 A modification and systemic lupus erythematosus
  121. Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis
  122. Coagulation cascade and complement system in systemic lupus erythematosus
  123. Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs
  124. Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients: A meta-analysis
  125. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis
  126. Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus
  127. Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus
  128. Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis
  129. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus
  130. Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis
  131. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis
  132. Altered microRNAs expression in T cells of patients with SLE involved in the lack of vitamin D
  133. Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis
  134. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases
  135. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis
  136. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
  137. Effect of Short Message Service on Management of Pulmonary Tuberculosis Patients in Anhui Province, China: A Prospective, Randomized, Controlled Study
  138. Association of HLA-DQB1 polymorphisms with rheumatoid arthritis: a meta-analysis
  139. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus
  140. Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population
  141. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus
  142. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis
  143. Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
  144. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
  145. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
  146. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus
  147. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis
  148. Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
  149. Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus risk: an updated meta-analysis
  150. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis
  151. Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
  152. Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus
  153. A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn’s disease and ulcerative colitis
  154. Plasma levels of adipokines in systemic lupus erythematosus patients
  155. Evidence of epistatic interaction betweenDPP4andCCR6in patients with rheumatoid arthritis
  156. Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis
  157. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis
  158. Circular RNAs and systemic lupus erythematosus
  159. Plasma melatonin levels do not differ in SLE patients
  160. MicroRNA-210 and its theranostic potential
  161. Emerging role of adipokines in systemic lupus erythematosus
  162. Relationship between the IL12B (rs3212227) gene polymorphism and susceptibility to multiple autoimmune diseases: A meta-analysis
  163. TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis
  164. Association between rs6887695 and 3′-untranslated region polymorphisms within theinterleukin-12Bgene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis
  165. Genetic Polymorphism (rs329498) in the Pellino-1 Gene as Possible Predisposal Factor for Systemic Lupus Erythematosus in a Chinese Population
  166. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment
  167. Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population
  168. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
  169. Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus
  170. Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis
  171. Therapeutic potential of IL-15 in rheumatoid arthritis
  172. Gene-Based Meta-Analysis of Genome-Wide Association Study Data Identifies Independent Single-Nucleotide Polymorphisms inANXA6as Being Associated With Systemic Lupus Erythematosus in Asian Populations
  173. Association Study of Matrix Metalloproteinases Gene Polymorphisms with Susceptibility to Rheumatoid Arthritis: A Meta-Analysis
  174. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  175. Emerging role of long noncoding RNAs in autoimmune diseases
  176. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus
  177. Association of UBASH3A gene polymorphisms and systemic lupus erythematosus in a Chinese population
  178. Increased carotid intima–media thickness (CIMT) levels in patients with type 1 diabetes mellitus (T1DM): A meta-analysis
  179. Epidemiological characteristics and influential factors of hand, foot and mouth disease (HFMD) reinfection in children in Anhui province
  180. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis
  181. Associations Between PADI4 Gene Polymorphisms and Rheumatoid Arthritis: An Updated Meta-analysis
  182. Association of lymphotoxin alpha polymorphism with systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis
  183. Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
  184. A literature review on the patients with autoimmune diseases following vaccination against infections
  185. Genome-wide search followed by replication reveals genetic interaction ofCD80andALOX5APassociated with systemic lupus erythematosus in Asian populations
  186. Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus
  187. IL-17A-producing CD8+T cells as therapeutic targets in autoimmunity
  188. Association between CARD8 rs2043211 Polymorphism and Inflammatory Bowel Disease: A Meta-Analysis
  189. microRNAs function in CD8+ T cell biology
  190. Long noncoding RNAs: Novel insights into gastric cancer
  191. Novel insights into Tim-4 function in autoimmune diseases
  192. The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity
  193. Tc17 Cells in Immunity and Systemic Autoimmunity
  194. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus
  195. Association of IL-21 polymorphisms (rs907715, rs2221903) with susceptibility to multiple autoimmune diseases: A meta-analysis
  196. Association of FCGR2A-R/H131 polymorphism with susceptibility to systemic lupus erythematosus among Asian population: a meta-analysis of 20 studies
  197. Decreased Flow-Mediated Dilatation in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  198. The Risk Factors of Avascular Necrosis in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  199. Therapeutic potential of STAT4 in autoimmunity
  200. Emerging Role of SIGIRR rs7396562(T/G) Polymorphism in Systemic Lupus Erythematosus in a Chinese Population
  201. Therapeutic Potential of HO-1 in Autoimmune Diseases
  202. Association study ofinterleukin-19 rs2243188polymorphism with systemic lupus erythematosus in a Chinese population
  203. CTLA-4 CT60(rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis
  204. SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications
  205. Therapeutic potential of tyrosine kinase 2 in autoimmunity
  206. Relationship between the IL-4 gene promoter -590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis
  207. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: A meta-analysis
  208. Associations between TNF gene polymorphisms (−308 A/G, −238 A/G, −1031 C/T and −857 T/C) and genetic susceptibility to T1D: a meta-analysis
  209. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis
  210. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus
  211. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis
  212. Serum levels of cytokines in systemic lupus erythematosus
  213. New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus
  214. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases
  215. Association of XPC Gene Polymorphisms with Susceptibility to Prostate Cancer: Evidence from 3,936 Subjects
  216. Genetic interaction between genes involved in NF-κB signaling pathway in systemic lupus erythematosus
  217. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk
  218. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province
  219. Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus
  220. Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population
  221. Expression of Ets-1 and FOXP3 mRNA in CD4+CD25+ T regulatory cells from patients with systemic lupus erythematosus
  222. Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study
  223. Associations of Interleukin-4 Receptor Gene Polymorphisms (Q551R, I50V) with Rheumatoid Arthritis: Evidence from a Meta-Analysis
  224. Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: A meta-analysis
  225. Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians
  226. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis
  227. Identification of MFG-E8 as a novel therapeutic target for diseases
  228. Perspectives of the relationship between IL-7 and autoimmune diseases
  229. Impact of Environmental Factors on Efficacy of Glucocorticoids in Chinese Population with Systemic Lupus Erythematosus
  230. IL-10RB rs2834167 (A/G) Polymorphism Is Associated with the Susceptibility to Systemic Lupus Erythematosus: Evidence from a Study in Chinese Han Population
  231. Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population
  232. A bibliometric study of literature on SLE research in PubMed (2002–2011)
  233. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: A meta-analysis
  234. Decreased ITGAM and FcγRIIIA mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  235. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
  236. Association between leptin and systemic lupus erythematosus
  237. IL-32 with potential insights into rheumatoid arthritis
  238. Association of the −1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis
  239. Therapeutic potential of SIGIRR in systemic lupus erythematosus
  240. D18S880 Microsatellite Polymorphism of Carnosinase Gene and Diabetic Nephropathy: A Meta-Analysis
  241. Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients
  242. Sex-specific differences in the relationship between the single-nucleotide polymorphism rs2298804 ofFCER1Aand the susceptibility to systemic lupus erythematosus in a Chinese Han population
  243. MicroRNA-21 with therapeutic potential in autoimmune diseases
  244. Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis
  245. Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population
  246. Emerging role of interleukin-22 in autoimmune diseases
  247. CTLA-4 -1722T/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-analysis Involving Ten Separate Studies
  248. Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians
  249. Interferon regulatory factor 5 and autoimmune lupus
  250. Association of interleukin-18 and systemic lupus erythematosus
  251. Gene–Gene and Gene-Sex Epistatic Interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in Systemic Lupus Erythematosus
  252. IL-33
  253. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: A meta-analysis
  254. Association of the interleukin-10 gene polymorphism (–1082A/G) with systemic lupus erythematosus: a meta-analysis
  255. MicroRNA-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus
  256. Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population
  257. Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis
  258. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus
  259. Targeting IRF4 in autoimmune diseases
  260. Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population
  261. Association of TNFSF4 polymorphisms with systemic lupus erythematosus: a meta-analysis
  262. Association of Interleukin 1α Promoter Polymorphism (–889C/T) with Susceptibility to Systemic Sclerosis
  263. Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis
  264. A Single Nucleotide Polymorphism of IL-21 Gene is Associated with Systemic Lupus Erythematosus in a Chinese Population
  265. Association of c-Jun Gene Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Chinese Population
  266. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
  267. Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis
  268. Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis
  269. IRF7, a functional factor associates with systemic lupus erythematosus
  270. APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al
  271. Association of MicroRNA-146a with Autoimmune Diseases
  272. The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus
  273. New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: Comment on the article by Ichikawa et al
  274. New evidence for a role ofMICAin the pathogenesis of systemic lupus erythematosus: Comment on the article by Yoshida et al
  275. Association of PTPN22 C1858T Polymorphism and Type 1 Diabetes: A Meta-analysis
  276. Role of CREM in systemic lupus erythematosus
  277. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE
  278. Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis
  279. New evidence for roles of antinucleosome antibodies in systemic lupus erythematosus
  280. A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis
  281. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China
  282. Interleukin-18: Friend or Foe for Systemic Sclerosis?
  283. Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population
  284. Association of CD247 with systemic lupus erythematosus in Asian populations
  285. Targeting IL-6 promoter polymorphism −174G/C should be dependent on ethnicity
  286. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus
  287. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience
  288. Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors
  289. Lack of association of interleukin-18 gene promoter −607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis
  290. Role of microRNA-155 in autoimmunity
  291. The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus
  292. The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis
  293. Is transforming growth factor β always necessary for generation of pathogenic Th17 cells in autoimmune disease? Comment on the article by Morita et al
  294. Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis
  295. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients
  296. Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis
  297. Association of interleukin-6 promoter polymorphism (−174 G/C) with systemic lupus erythematosus
  298. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention
  299. Polymorphisms of the TIM-1 and TIM-3 genes are not associated with systemic lupus erythematosus in a Chinese population
  300. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
  301. Association of ITGAM polymorphism with systemic lupus erythematosus: a meta-analysis
  302. Osteopontin receptor-dependent regulation of Th1 and Th17 responses in autoimmune diseases: Comment on the article by Chen et al
  303. Increased serum RANTES in patients with systemic lupus erythematosus
  304. Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus
  305. Saikosaponins: a potential treatment option for systemic lupus erythematosus
  306. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus
  307. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases
  308. ELF1 is associated with systemic lupus erythematosus in Asian populations
  309. Epidemiological investigation of scarlet fever in Hefei City, China, from 2004 to 2008
  310. Prevalence and clinical significance of 15 autoantibodies in patients with new-onset systemic lupus erythematosus
  311. Elevated serum levels of MMP-2, MMP-3, and MMP-13 in Chinese patients with systemic lupus erythematosus
  312. Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?
  313. The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease
  314. Tumor necrosis factor-α-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations
  315. 1,25-Dihydroxyvitamin D3 may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: Comment on the article by Colin et al
  316. Anti-Ro antibody and clinical manifestations: lessons from systemic lupus erythematosus in the elderly
  317. Family Factors Associated With Suicide Attempts Among Chinese Adolescent Students: A National Cross-Sectional Survey
  318. BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus
  319. Comment on “Human Pregnancy Up-regulates Tim-3 in Innate Immune Cells for Systemic Immunity”
  320. IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
  321. Serum IL-17 level in systemic lupus erythematosus patients
  322. TWEAK as a target for therapy in systemic lupus erythematosus
  323. Therapeutic potential of IL-27 in systemic lupus erythematosus
  324. Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison
  325. Lack of association of FcγRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis
  326. A meta-analysis of the association of STAT4 polymorphism with systemic lupus erythematosus
  327. Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus
  328. Role of the Fcγ receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis
  329. Protective role of moderate alcohol drinking in systemic lupus erythematosus
  330. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus
  331. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls
  332. Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis
  333. TIM-3 as a new therapeutic target in systemic lupus erythematosus
  334. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases
  335. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma
  336. Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population
  337. Tuberculosis in systemic lupus erythematosus in Chinese patients
  338. Paclitaxel: Friend or Foe for Systemic Lupus Erythematosus?
  339. Season of birth: A potential influential factor for quality of life
  340. Increased serum interleukin 17 in patients with systemic lupus erythematosus
  341. Anti-α-actinin antibodies in relation to new-onset systemic lupus erythematosus and lupus nephritis
  342. Decreased serum IL-22 levels in patients with systemic lupus erythematosus
  343. High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus
  344. FAS −1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls
  345. Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases
  346. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese
  347. Susceptibility to systemic lupus erythematosus may be related to gene dosage effect of the X chromosome
  348. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis
  349. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus
  350. Metabolic syndrome: A potential culprit for Alzheimer’s disease?
  351. Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis
  352. Radix Astragali: A promising new treatment option for systemic lupus erythematosus
  353. Meta analysis on the association between FcγRIIa-R/H131 polymorphisms and systemic lupus erythematosus
  354. Anti-neutrophil Cytoplasmic Antibodies in New-onset Systemic Lupus Erythematosus and Lupus Nephritis
  355. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus
  356. Reactivation of inactive X chromosome: A potential culprit and therapeutic target for Systemic lupus erythematosus
  357. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients